2 news items
Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management
SENS
13 May 24
System is a prescription device; patients should talk to their health care provider to learn more. For important safety information, see
Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution
SENS
9 May 24
and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study
- Prev
- 1
- Next